 |
 |
||||||
 |
Our customers' Feedback |
Your cart
$0.00 (0 items)
| |||||
Generic Dutasteride - Avodart
| ||||||
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth.
- Sildenafil citrate and pulmonary arterial hypertension
Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure.
- Fruit and vegetables do not reduce overall cancer risk, review concludes
Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people.
- Common painkillers could be linked to male reproductive disorder
The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study.
Our billing is certified by:
- Dutasteride May Slow Prostate Cancer Progression - OncLive
OncLiveDutasteride May Slow Prostate Cancer ProgressionOncLiveDutasteride, a 5α-reductase inhibitor approved for the treatment of benign prostatic hyperplasia, may postpone disease progression in men with low-risk prostate cancer who have opted for an active surveillance strategy, as well as the need to start .
- Coronary Artery Disease May Boost Risk of Prostate Cancer - OncLive
OncLiveCoronary Artery Disease May Boost Risk of Prostate CancerOncLiveThe 4-year, phase III REDUCE study evaluated the 5α-reductase inhibitor dutasteride, 0.
- Regular Prostate Treatment with New Thermobalancing Therapy Maintains Men's ... - Virtual-Strategy Magazine
Regular Prostate Treatment with New Thermobalancing Therapy Maintains Men's .
- New Therapy Is Essential for Men with Prostate Enlargement As Medications Have ... - Seattle Post Intelligencer
New Therapy Is Essential for Men with Prostate Enlargement As Medications Have .
- 5-alpha Reductase Inhibitors Help Prostate Cancer Patients on Active Surveillance - OncLive
OncLive5-alpha Reductase Inhibitors Help Prostate Cancer Patients on Active SurveillanceOncLiveHe added that these findings are supported by the double-blind, placebo-controlled Reduction by Dutasteride of Clinical Progression Events in Expectant Management of Prostate Cancer (REDEEM) trial, which was recently published in The Lancet.
|
| Copyright © 2006-2012 Canada Drug Pharmacy is an affiliate marketing website |
